ÂÜÀòÂÒÂ×

Jason Dinges is an experienced investment professional and intellectual property counsel, currently serving at Morningside Technology Advisory LLC since February 2011. In addition to this role, Jason holds multiple board member positions at various companies, including Geneoscopy, Vesigen Therapeutics, Alentis Therapeutics, Prilenia, Intellihealth, Inotrem SA, ZielBio, Inc., IM Therapeutics, and Adiso Therapeutics. Jason obtained a J.D. from the University of Iowa College of Law, a Ph.D. in Genetics from Iowa State University, and a B.S. in Biology from Illinois Wesleyan University.